Abeona appoints new chief as Timothy Miller moves to CSO; Maxine Gowen passes Trevena baton to Carrie Bourdow; Scott Smith out in Celgene revamp
→ In a sign of renewed focus, Abeona Therapeutics $ABEO has scooped Alexion’s Carsten Thiel to become its new chief, freeing up Timothy Miller to take on the CSO role while remaining as president. The board likes Thiel’s commercialization work on rare diseases at Alexion, as well as his operational track record at Amgen, and hopes he will put it all to use. As for Miller, he will focus on the ever-growing lineup of preclinical and clinical cell and gene therapy programs for rare genetic diseases.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
